Emerging airway smooth muscle targets to treat asthma

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 1, 2013, Pages 132-144

  Siddiqui, Sana ^a,i   Redhu, Naresh Singh ^b   Ojo, Oluwaseun O ^c   Liu, Bo ^d   Irechukwu, Nneka ^e   Billington, Charlotte ^d   Janssen, Luke ^f   Moir, Lyn M ^g,h  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f ST JOSEPH S HOSPITAL   (Canada)

^g WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Airway hyperreactivity; Asthma; Bronchial thermoplasty; Calcium; Contraction; GPCRs; IgE; Kinases

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANTIASTHMATIC AGENT; ANTIHISTAMINIC AGENT; AZAINDOLE 1; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLOPIAZONIC ACID; ERLOTINIB; FASUDIL; GEFITINIB; GENISTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMATINIB; INDACATEROL; MASITINIB; PHOSPHODIESTERASE INHIBITOR; PICEATANNOL; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RHO KINASE; RHO KINASE INHIBITOR; ROFLUMILAST; SALBUTAMOL; SUNITINIB; TERBUTALINE; THEOPHYLLINE; TYRPHOSTIN; UNCLASSIFIED DRUG;

AIRWAY SMOOTH MUSCLE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BITTER TASTE; BRAIN VASOSPASM; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DRUG POTENTIATION; DRUG TARGETING; HUMAN; INTERCELLULAR SPACE; LABORATORY; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; SODIUM CALCIUM EXCHANGE; TASTE BUD; TREATMENT PLANNING;

AIRWAY OBSTRUCTION; AIRWAY REMODELING; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; DRUG DESIGN; HUMANS; INFLAMMATION; MOLECULAR TARGETED THERAPY; MUSCLE, SMOOTH;

EID: 84873184019     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.08.008     Document Type: Article

References (173)

1. Billington C.K., Penn R.B. Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir Res 2003, 4:2.
2. Deshpande D.A., Penn R.B. Targeting G protein-coupled receptor signaling in asthma. Cell Signal 2006, 18:2105-2120.
3. Deshpande D.A., Theriot B.S., Penn R.B., Walker J.K. Beta-arrestins specifically constrain beta2-adrenergic receptor signaling and function in airway smooth muscle. FASEB J 2008, 22:2134-2141.
4. Kong K.C., Gandhi U., Martin T.J., Anz C.B., Yan H., Misior A.M., et al. Endogenous Gs-coupled receptors in smooth muscle exhibit differential susceptibility to GRK2/3-mediated desensitization. Biochemistry 2008, 47:9279-9288.
5. Cooper P.R., Panettieri R.A. Steroids completely reverse albuterol-induced beta(2)-adrenergic receptor tolerance in human small airways. J Allergy Clin Immunol 2008, 122:734-740.
6. Cooper P.R., Kurten R.C., Zhang J., Nicholls D.J., Dainty I.A., Panettieri R.A. Formoterol and salmeterol induce a similar degree of beta2-adrenoceptor tolerance in human small airways but via different mechanisms. Br J Pharmacol 2011, 163:521-532.
7. Dickey B.F., Walker J.K., Hanania N.A., Bond R.A. Beta-adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol 2010, 10:254-259.
8. Sears M.R. Safe use of long-acting beta-agonists: what have we learnt?. Expert Opin Drug Saf 2011, 10:767-778.
9. Penn R.B. Agonizing over agonism: should asthmatics turn their beta-receptors on or off?. Proc Natl Acad Sci U S A 2009, 106:2095-2096.
10. Lin R., Peng H., Nguyen L.P., Dudekula N.B., Shardonofsky F., Knoll B.J., et al. Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model. Pulm Pharmacol Ther 2008, 21:115-124.
11. Nguyen L.P., Lin R., Parra S., Omoluabi O., Hanania N.A., Tuvim M.J., et al. Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A 2009, 106:2435-2440.
12. Nguyen L.P., Singh B., Okulate A.A., Alfaro V.Y., Tuvim M.J., Dickey B.F., et al. Complementary anti-inflammatory effects of a beta-blocker and a corticosteroid in an asthma model. Naunyn Schmiedebergs Arch Pharmacol 2012, 385:203-210.
13. Callaerts-Vegh Z., Evans K.L., Dudekula N., Cuba D., Knoll B.J., Callaerts P.F., et al. Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci U S A 2004, 101:4948-4953.
14. Nguyen L.P., Omoluabi O., Parra S., Frieske J.M., Clement C., Ammar-Aouchiche Z., et al. Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol 2008, 38:256-262.
15. Walker J.K., Penn R.B., Hanania N.A., Dickey B.F., Bond R.A. New perspectives regarding beta(2) -adrenoceptor ligands in the treatment of asthma. Br J Pharmacol 2011, 163:18-28.
16. Pera T., Zuidhof A., Valadas J., Smit M., Schoemaker R.G., Gosens R., et al. Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD. Eur Respir J 2011, 38:789-796.
17. Mori A., Ito S., Morioka M., Aso H., Kondo M., Sokabe M., et al. Effects of specific prostanoid EP receptor agonists on cell proliferation and intracellular Ca(2+) concentrations in human airway smooth muscle cells. Eur J Pharmacol 2011, 659:72-78.
18. Deshpande D.A., Wang W.C., McIlmoyle E.L., Robinett K.S., Schillinger R.M., An S.S., et al. Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat Med 2010, 16:1299-1304.
19. Coburn R.F., Yamaguchi T. Membrane potential-dependent and-independent tension in the canine tracheal muscle. J Pharmacol Exp Ther 1977, 201:276-284.
20. Coburn R.F., Baron C.B. Coupling mechanisms in airway smooth muscle. Am J Physiol 1990, 258:L119-L133.
21. Janssen L.J. Ionic mechanisms and Ca(2+) regulation in airway smooth muscle contraction: do the data contradict dogma?. Am J Physiol Lung Cell Mol Physiol 2002, 282:L1161-L1178.
22. Robinett K.S., Deshpande D.A., Malone M.M., Liggett S.B. Agonist-promoted homologous desensitization of human airway smooth muscle bitter taste receptors. Am J Respir Cell Mol Biol 2011, 45:1069-1074.
23. Morice A.H., Bennett R.T., Chaudhry M.A., Cowen M.E., Griffin S.C., Loubani M., et al. Effect of bitter tastants on human bronchi. Nat Med 2011, 17:775.
24. Bingham J., Sudarsanam S., Srinivasan S. Profiling human phosphodiesterase genes and splice isoforms. Biochem Biophys Res Commun 2006, 350:25-32.
25. Pang L., Knox A.J. Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids. FASEB J 2001, 15:261-269.
26. Torphy T.J., Undem B.J., Cieslinkski L.B., Luttmann M.A., Reeves M.L., Hay D.W. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J Pharmacol Exp Ther 1993, 265:1213-1223.
27. Trian T., Burgess J.K., Niimi K., Moir L.M., Ge Q., Berger P., et al. Beta2-Agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4D. PLoS One 2011, 6:e20000.
28. Bundschuh D.S., Eltze M., Barsig J., Wollin L., Hatzelmann A., Beume R. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. J Pharmacol Exp Ther 2001, 297:280-290.
29. Rabe K.F., Tenor H., Dent G., Schudt C., Liebig S., Magnussen H. Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization. Am J Physiol 1993, 264:L458-L464.
30. Schmidt D.T., Watson N., Dent G., Rühlmann E., Branscheid D., Magnussen H., et al. The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways. Br J Pharmacol 2000, 131:1607-1618.
31. Billington C.K., Le Jeune I.R., Young K.W., Hall I.P. A major functional role for phosphodiesterase 4D5 in human airway smooth muscle cells. Am J Respir Cell Mol Biol 2008, 38:1-7.
32. Niimi K., Ge Q., Moir L.M., Ammit A.J., Trian T., Burgess J.K., et al. Beta2-Agonists upregulate PDE4 mRNA but not protein or activity in human airway smooth muscle cells from asthmatic and nonasthmatic volunteers. Am J Physiol Lung Cell Mol Physiol 2012, 302:L334-L342.
33. Mehats C., Jin S.L., Wahlstrom J., Law E., Umetsu D.T., Conti M. PDE4D plays a critical role in the control of airway smooth muscle contraction. FASEB J 2003, 17:1831-1841.
34. Himes B.E., Hunninghake G.M., Baurley J.W., Rafaels N.M., Sleiman P., Strachan D.P., et al. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet 2009, 84:581-593.
35. Trian T., Benard G., Begueret H., Rossignol R., Girodet P.O., Ghosh D., et al. Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma. J Exp Med 2007, 204:3173-3181.
36. Johnson P.R., Roth M., Tamm M., Hughes M., Ge Q., King G., et al. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001, 164:474-477.
37. Goncharova E.A., Billington C.K., Irani C., Vorotnikov A.V., Tkachuk V.A., Penn R.B., et al. Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration. Am J Respir Cell Mol Biol 2003, 29:19-27.
38. Burgess J.K., Oliver B.G., Poniris M.H., Ge Q., Boustany S., Cox N., et al. A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro. J Allergy Clin Immunol 2006, 118:649-657.
39. Rabe K.F., Bateman E.D., O'Donnell D., Witte S., Bredenbröker D., Bethke T.D. Roflumilast-an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2005, 366:563-571.
40. Rennard S.I., Calverley P.M., Goehring U.M., Bredenbroker D., Martinez F.J. Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD. Respir Res 2011, 12:18.
41. Calverley P.M., Sanchez-Toril F., McIvor A., Teichmann P., Bredenbroeker D., Fabbri L.M. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 176:154-161.
42. Harbinson P.L., MacLeod D., Hawksworth R., O'Toole S., Sullivan P.J., Heath P., et al. The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects. Eur Respir J 1997, 10:1008-1014.
43. van Schalkwyk E., Strydom K., Williams Z., Venter L., Leichtl S., Schmid-Wirlitsch C., et al. Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions. J Allergy Clin Immunol 2005, 116:292-298.
44. Bateman E.D., Izquierdo J.L., Harnest U., Hofbauer P., Magyar P., Schmid-Wirlitsch C., et al. Efficacy and safety of roflumilast in the treatment of asthma. Ann Allergy Asthma Immunol 2006, 96:679-686.
45. Gauvreau G.M., Boulet L.P., Schmid-Wirlitsch C., Côté J., Duong M., Killian K.J., et al. Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects. Respir Res 2011, 12:140.
46. Bousquet J., Aubier M., Sastre J., Izquierdo J.L., Adler L.M., Hofbauer P., et al. Comparison of roflumilast, an oral anti-inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma. Allergy 2006, 61:72-78.
47. Tannheimer S.L., Wright C.D., Salmon M. Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts. Respir Res 2012, 13:28.
48. Janssen L.J., Killian K. Airway smooth muscle as a target of asthma therapy: history and new directions. Respir Res 2006, 7:123.
49. Du W., McMahon T.J., Zhang Z.S., Stiber J.A., Meissner G., Eu J.P., et al. Excitation-contraction coupling in airway smooth muscle. J Biol Chem 2006, 281:30143-30151.
50. Liu C., Zuo J., Pertens E., Helli P.B., Janssen L.J. Regulation of Rho/ROCK signaling in airway smooth muscle by membrane potential and [Ca2+]i. Am J Physiol Lung Cell Mol Physiol 2005, 289:L574-L582.
51. Worley J.F., Kotlikoff M.I. Dihydropyridine-sensitive single calcium channels in airway smooth muscle cells. Am J Physiol 1990, 259:L468-L480.
52. Tomasic M., Boyle J.P., Worley J.F., Kotlikoff M.I. Contractile agonists activate voltage-dependent calcium channels in airway smooth muscle cells. Am J Physiol 1992, 263:C106-C113.
53. Talwar D., Jindal S.K. Effect of calcium channel antagonists on cholinergic bronchial responsiveness in asthma. J Assoc Physicians India 1993, 41:279-280.
54. Gordon E.H., Wong S.C., Klaustermeyer W.B. Comparison of nifedipine with a new calcium channel blocker, flordipine, in exercise-induced asthma. J Asthma 1987, 24:261-265.
55. Mahn K., Ojo O.O., Chadwick G., Aaronson P.I., Ward J.P., Lee T.H. Ca(2+) homeostasis and structural and functional remodelling of airway smooth muscle in asthma. Thorax 2010, 65:547-552.
56. Cabral M.D., Paulet P.E., Robert V., Gomes B., Renoud M.L., Savignac M., et al. Knocking down Cav1 calcium channels implicated in Th2 cell activation prevents experimental asthma. Am J Respir Crit Care Med 2010, 181:1310-1317.
57. Peel S.E., Liu B., Hall I.P. ORAI and store-operated calcium influx in human airway smooth muscle cells. Am J Respir Cell Mol Biol 2008, 38:744-749.
58. Helli P.B., Pertens E., Janssen L.J. Cyclopiazonic acid activates a Ca2+-permeable, nonselective cation conductance in porcine and bovine tracheal smooth muscle. J Appl Physiol 2005, 99:1759-1768.
59. Helli P.B., Janssen L.J. Properties of a store-operated nonselective cation channel in airway smooth muscle. Eur Respir J 2008, 32:1529-1539.
60. Peel S.E., Liu B., Hall I.P. A key role for STIM1 in store operated calcium channel activation in airway smooth muscle. Respir Res 2006, 7:119.
61. Ohga K., Takezawa R., Yoshino T., Yamada T., Shimizu Y., Ishikawa J. The suppressive effects of YM-58483/BTP-2, a store-operated Ca2+ entry blocker, on inflammatory mediator release in vitro and airway responses in vivo. Pulm Pharmacol Ther 2008, 21:360-369.
62. Zou J.J., Gao Y.D., Geng S., Yang J. Role of STIM1/Orai1-mediated store-operated Ca(2) entry in airway smooth muscle cell proliferation. J Appl Physiol 2011, 110:1256-1263.
63. Deshpande D.A., Walseth T.F., Panettieri R.A., Kannan M.S. CD38/cyclic ADP-ribose-mediated Ca2+ signaling contributes to airway smooth muscle hyper-responsiveness. FASEB J 2003, 17:452-454.
64. Deshpande D.A., Dogan S., Walseth T.F., Miller S.M., Amrani Y., Panettieri R.A., et al. Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. Am J Respir Cell Mol Biol 2004, 31:36-42.
65. Gally F., Hartney J.M., Janssen W.J., Perraud A.L. CD38 plays a dual role in allergen-induced airway hyperresponsiveness. Am J Respir Cell Mol Biol 2009, 40:433-442.
66. Gosling M., Poll C., Li S. TRP channels in airway smooth muscle as therapeutic targets. Naunyn Schmiedebergs Arch Pharmacol 2005, 371:277-284.
67. Snetkov V.A., Hapgood K.J., McVicker C.G., Lee T.H., Ward J.P. Mechanisms of leukotriene D4-induced constriction in human small bronchioles. Br J Pharmacol 2001, 133:243-252.
68. Sweeney M., McDaniel S.S., Platoshyn O., Zhang S., Yu Y., Lapp B.R., et al. Role of capacitative Ca2+ entry in bronchial contraction and remodeling. J Appl Physiol 2002, 92:1594-1602.
69. Corteling R.L., Li S., Giddings J., Westwick J., Poll C., Hall I.P. Expression of transient receptor potential C6 and related transient receptor potential family members in human airway smooth muscle and lung tissue. Am J Respir Cell Mol Biol 2004, 30:145-154.
70. Jia Y., Wang X., Varty L., Rizzo C.A., Yang R., Correll C.C., et al. Functional TRPV4 channels are expressed in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2004, 287:L272-L278.
71. White T.A., Xue A., Chini E.N., Thompson M., Sieck G.C., Wylam M.E. Role of transient receptor potential C3 in TNF-alpha-enhanced calcium influx in human airway myocytes. Am J Respir Cell Mol Biol 2006, 35:243-251.
72. Hofmann T., Schaefer M., Schultz G., Gudermann T. Subunit composition of mammalian transient receptor potential channels in living cells. Proc Natl Acad Sci U S A 2002, 99:7461-7466.
73. Xiao J.H., Zheng Y.M., Liao B., Wang Y.X. Functional role of canonical transient receptor potential 1 and canonical transient receptor potential 3 in normal and asthmatic airway smooth muscle cells. Am J Respir Cell Mol Biol 2010, 43:17-25.
74. Liao Y., Plummer N.W., George M.D., Abramowitz J., Zhu M.X., Birnbaumer L. A role for Orai in TRPC-mediated Ca2+ entry suggests that a TRPC: Orai complex may mediate store and receptor operated Ca2+ entry. Proc Natl Acad Sci U S A 2009, 106:3202-3206.
75. Sathish V., Thompson M.A., Bailey J.P., Pabelick C.M., Prakash Y.S., Sieck G.C. Effect of proinflammatory cytokines on regulation of sarcoplasmic reticulum Ca2+ reuptake in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2009, 297:L26-L34.
76. Mahn K., Hirst S.J., Ying S., Holt M.R., Lavender P., Ojo O.O., et al. Diminished sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma. Proc Natl Acad Sci U S A 2009, 106:10775-10780.
77. Kawase Y., Ly H.Q., Prunier F., Lebeche D., Shi Y., Jin H., et al. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J Am Coll Cardiol 2008, 51:1112-1119.
78. Schmidt U., del Monte F., Miyamoto M.I., Matsui T., Gwathmey J.K., Rosenzweig A., et al. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circulation 2000, 101:790-796.
79. Miyamoto M.I., del Monte F., Schmidt U., DiSalvo T.S., Kang Z.B., Matsui T., et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A 2000, 97:793-798.
80. Niwano K., Arai M., Koitabashi N., Watanabe A., Ikeda Y., Miyoshi H., et al. Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats. Mol Ther 2008, 16:1026-1032.
81. Rahman M., Inman M., Kiss L., Janssen L.J. Reverse-mode NCX current in mouse airway smooth muscle: Na(+) and voltage dependence, contributions to Ca(2+) influx and contraction, and altered expression in a model of allergen-induced hyperresponsiveness. Acta Physiol (Oxf) 2011, 205:279-291.
82. Janssen L.J. Acetylcholine and caffeine activate Cl- and suppress K+ conductances in human bronchial smooth muscle. Am J Physiol 1996, 270:L772-L781.
83. Hirota S., Helli P., Janssen L.J. Ionic mechanisms and Ca2+ handling in airway smooth muscle. Eur Respir J 2007, 30:114-133.
84. Hirota S., Janssen L.J. Store-refilling involves both L-type calcium channels and reverse-mode sodium-calcium exchange in airway smooth muscle. Eur Respir J 2007, 30:269-278.
85. Hirota S., Pertens E., Janssen L.J. The reverse mode of the Na(+)/Ca(2+) exchanger provides a source of Ca(2+) for store refilling following agonist-induced Ca(2+) mobilization. Am J Physiol Lung Cell Mol Physiol 2007, 292:L438-L447.
86. Krymskaya V.P., Ammit A.J., Hoffman R.K., Eszterhas A.J., Panettieri R.A. Activation of class IA PI3K stimulates DNA synthesis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2001, 280:L1009-L1018.
87. Moir L.M., Trian T., Ge Q., Shepherd P.R., Burgess J.K., Oliver B.G., et al. Phosphatidylinositol 3-kinase isoform-specific effects in airway mesenchymal cell function. J Pharmacol Exp Ther 2011, 337:557-566.
88. Ge Q., Moir L.M., Trian T., Niimi K., Poniris M., Shepherd P.R., et al. The phosphoinositide 3'-kinase p110delta modulates contractile protein production and IL-6 release in human airway smooth muscle. J Cell Physiol 2011, 227:3044-3052.
89. Duan W., Aguinaldo Datiles A.M., Leung B.P., Vlahos C.J., Wong W.S. An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol 2005, 5:495-502.
90. Ohta Y., Hayashi M., Kanemaru T., Abe K., Ito Y., Oike M. Dual modulation of airway smooth muscle contraction by Th2 cytokines via matrix metalloproteinase-1 production. J Immunol 2008, 180:4191-4199.
91. Halayko A.J., Kartha S., Stelmack G.L., McConville J., Tam J., Camoretti-Mercado B., et al. Phophatidylinositol-3 kinase/mammalian target of rapamycin/p70S6K regulates contractile protein accumulation in airway myocyte differentiation. Am J Respir Cell Mol Biol 2004, 31:266-275.
92. Tolloczko B., Turkewitsch P., Al Chalabi M., Martin J.G. LY-294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] affects calcium signaling in airway smooth muscle cells independently of phosphoinositide 3-kinase inhibition. J Pharmacol Exp Ther 2004, 311:787-793.
93. Farghaly H.S., Blagbrough I.S., Medina-Tato D.A., Watson M.L. Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110delta-dependent mechanism. Mol Pharmacol 2008, 73:1530-1537.
94. Lee K.S., Lee H.K., Hayflick J.S., Lee Y.C., Puri K.D. Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J 2006, 20:455-465.
95. Walker T.R., Moore S.M., Lawson M.F., Panettieri R.A., Chilvers E.R. Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: role in mediating airway smooth muscle proliferation. Mol Pharmacol 1998, 54:1007-1015.
96. Burgess J.K., Lee J.H., Ge Q., Ramsay E.E., Poniris M.H., Parmentier J., et al. Dual ERK and phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: differences in asthma. J Cell Physiol 2008, 216:673-679.
97. Parameswaran K., Cox G., Radford K., Janssen L.J., Sehmi R., O'Byrne P.M. Cysteinyl leukotrienes promote human airway smooth muscle migration. Am J Respir Crit Care Med 2002, 166:738-742.
98. Johnson P.R., Burgess J.K., Ge Q., Poniris M., Boustany S., Twigg S.M., et al. Connective tissue growth factor induces extracellular matrix in asthmatic airway smooth muscle. Am J Respir Crit Care Med 2006, 173:32-41.
99. Bi L., Okabe I., Bernard D.J., Wynshaw-Boris A., Nussbaum R.L. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase. J Biol Chem 1999, 274:10963-10968.
100. Schaafsma D., Gosens R., Zaagsma J., Halayko A.J., Meurs H. Rho kinase inhibitors: a novel therapeutical intervention in asthma?. Eur J Pharmacol 2008, 585:398-406.
101. Kume H. RhoA/Rho-kinase as a therapeutic target in asthma. Curr Med Chem 2008, 15:2876-2885.
102. Dong M., Yan B.P., Liao J.K., Lam Y.Y., Yip G.W., Yu C.M. Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. Drug Discov Today 2010, 15:622-629.
103. Fernandes L.B., Henry P.J., Goldie R.G. Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease. Ther Adv Respir Dis 2007, 1:25-33.
104. Rokosz L.L., Beasley J.R., Carroll C.D., Lin T., Zhao J., Appell K.C., et al. Kinase inhibitors as drugs for chronic inflammatory and immunological diseases: progress and challenges. Expert Opin Ther Targets 2008, 12:883-903.
105. Somlyo A.P., Himpens B. Cell calcium and its regulation in smooth muscle. FASEB J 1989, 3:2266-2276.
106. Fukata Y., Amano M., Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 2001, 22:32-39.
107. Kureishi Y., Kobayashi S., Amano M., Kimura K., Kanaide H., Nakano T., et al. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 1997, 272:12257-12260.
108. Nakahara T., Moriuchi H., Yunoki M., Sakamato K., Ishii K. Y-27632 potentiates relaxant effects of beta 2-adrenoceptor agonists in bovine tracheal smooth muscle. Eur J Pharmacol 2000, 389:103-106.
109. Yoshii A., Iizuka K., Dobashi K., Horie T., Harada T., Nakazawa T., et al. Relaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitization. Am J Respir Cell Mol Biol 1999, 20:1190-1200.
110. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., Morishita T., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389:990-994.
111. Schaafsma D., Bos I.S., Zuidhof A.B., Zaagsma J., Meurs H. The inhaled Rho kinase inhibitor Y-27632 protects against allergen-induced acute bronchoconstriction, airway hyperresponsiveness, and inflammation. Am J Physiol Lung Cell Mol Physiol 2008, 295:L214-L219.
112. Janssen L.J., Wattie J., Lu-Chao H., Tazzeo T. Muscarinic excitation-contraction coupling mechanisms in tracheal and bronchial smooth muscles. J Appl Physiol 2001, 91:1142-1151.
113. Kast R., Schirok H., Figueroa-Pérez S., Mittendorf J., Gnoth M.J., Apeler H., et al. Cardiovascular effects of a novel potent and highly selective azaindole-based inhibitor of Rho-kinase. Br J Pharmacol 2007, 152:1070-1080.
114. Dahal B.K., Kosanovic D., Pamarthi P.K., Sydykov A., Lai Y.J., Kast R., et al. Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension. Eur Respir J 2010, 36:808-818.
115. Ediger T.L., Schulte N.A., Murphy T.J., Toews M.L. Transcription factor activation and mitogenic synergism in airway smooth muscle cells. Eur Respir J 2003, 21:759-769.
116. Chiba Y., Arima J., Sakai H., Misawa M. Lovastatin inhibits bronchial hyperresponsiveness by reducing RhoA signaling in rat allergic asthma. Am J Physiol Lung Cell Mol Physiol 2008, 294:L705-L713.
117. Takeda N., Kondo M., Ito S., Ito Y., Shimokata K., Kume H. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin. Am J Respir Cell Mol Biol 2006, 35:722-729.
118. Schaafsma D., Dueck G., Ghavami S., Kroeker A., Mutawe M.M., Hauff K., et al. The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle. Am J Respir Cell Mol Biol 2011, 44:394-403.
119. Tolloczko B., Tao F.C., Zacour M.E., Martin J.G. Tyrosine kinase-dependent calcium signaling in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2000, 278:L1138-L1145.
120. Robinson D.R., Wu Y.M., Lin S.F. The protein tyrosine kinase family of the human genome. Oncogene 2000, 19:5548-5557.
121. Hirst S.J., Martin J.G., Bonacci J.V., Chan V., Fixman E.D., Hamid Q.A., et al. Proliferative aspects of airway smooth muscle. J Allergy Clin Immunol 2004, 114:S2-17.
122. Burgel P.R., Nadel J.A. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 2004, 59:992-996.
123. Guntur V.P., Reinero C.R. The potential use of tyrosine kinase inhibitors in severe asthma. Curr Opin Allergy Clin Immunol 2012, 12:68-75.
124. Wong W.S. Inhibitors of the tyrosine kinase signaling cascade for asthma. Curr Opin Pharmacol 2005, 5:264-271.
125. Druker B.J., Tamura S., Buchdunger E., Ohno S., Segal G.M., Fanning S., et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996, 2:561-566.
126. Manley P.W., Cowan-Jacob S.W., Buchdunger E., Fabbro D., Fendrich G., Furet P., et al. Imatinib: a selective tyrosine kinase inhibitor. Eur J Cancer 2002, 38(Suppl. 5):S19-S27.
127. Hochhaus A., O'Brien S.G., Guilhot F., Druker B.J., Branford S., Foroni L., et al. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia 2009, 23:1054-1061.
128. Humbert M., de Blay F., Garcia G., Prud'homme A., Leroyer C., Magnan A., et al. Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics. Allergy 2009, 64:1194-1201.
129. Gould H.J., Sutton B.J. IgE in allergy and asthma today. Nat Rev Immunol 2008, 8:205-217.
130. Holgate S., Casale T., Wenzel S., Bousquet J., Deniz Y., Reisner C. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol 2005, 115:459-465.
131. Presta L.G., Lahr S.J., Shields R.L., Porter J.P., Gorman C.M., Fendly B.M., et al. Humanization of an antibody directed against IgE. J Immunol 1993, 151:2623-2632.
132. Rabe K.F., Calhoun W.J., Smith N., Jimenez P. Can anti-IgE therapy prevent airway remodeling in allergic asthma?. Allergy 2011, 66:1142-1151.
133. Berger P., Walls A.F., Marthan R., Tunon-de-Lara J.M. Immunoglobulin E-induced passive sensitization of human airways: an immunohistochemical study. Am J Respir Crit Care Med 1998, 157:610-616.
134. Hakonarson H., Carter C., Kim C., Grunstein M.M. Altered expression and action of the low-affinity IgE receptor FcepsilonRII (CD23) in asthmatic airway smooth muscle. J Allergy Clin Immunol 1999, 104:575-584.
135. Xia Y.C., Schuliga M., Shepherd M., Powell M., Harris T., Langenbach S.Y., et al. Functional expression of IgG-Fc receptors in human airway smooth muscle cells. Am J Respir Cell Mol Biol 2011, 44:665-672.
136. Redhu N.S., Gounni A.S. The high affinity IgE receptor (FcepsilonRI) expression and function in airway smooth muscle. Pulm Pharmacol Ther 2012, [e-pub ahead of print, PMID: 22580035].
137. Lee J.H., Kaminski N., Dolganov G., Grunig G., Koth L., Solomon C., et al. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am J Respir Cell Mol Biol 2001, 25:474-485.
138. Gounni A.S., Wellemans V., Yang J., Bellesort F., Kassiri K., Gangloff S., et al. Human airway smooth muscle cells express the high affinity receptor for IgE (Fc epsilon RI): a critical role of Fc epsilon RI in human airway smooth muscle cell function. J Immunol 2005, 175:2613-2621.
139. Roth M., Tamm M. The effects of omalizumab on IgE-induced cytokine synthesis by asthmatic airway smooth muscle cells. Ann Allergy Asthma Immunol 2010, 104:152-160.
140. Hakonarson H., Grunstein M.M. Autologously up-regulated Fc receptor expression and action in airway smooth muscle mediates its altered responsiveness in the atopic asthmatic sensitized state. Proc Natl Acad Sci U S A 1998, 95:5257-5262.
141. Gounni A.S. The high-affinity IgE receptor (FcepsilonRI): a critical regulator of airway smooth muscle cells?. Am J Physiol Lung Cell Mol Physiol 2006, 291:L312-L321.
142. Redhu N.S., Saleh A., Shan L., Gerthoffer W.T., Kung S.K., Halayko A.J., et al. Proinflammatory and Th2 cytokines regulate the high affinity IgE receptor (FcepsilonRI) and IgE-dependant activation of human airway smooth muscle cells. PLoS One 2009, 4:e6153.
143. Margulis A., Nocka K.H., Brennan A.M., Deng B., Fleming M., Goldman S.J., et al. Mast cell-dependent contraction of human airway smooth muscle cell-containing collagen gels: influence of cytokines, matrix metalloproteases, and serine proteases. J Immunol 2009, 183:1739-1750.
144. Redhu N.S., Saleh A., Lee H.C., Halayko A.J., Ziegler S.F., Gounni A.S. IgE induces transcriptional regulation of thymic stromal lymphopoietin in human airway smooth muscle cells. J Allergy Clin Immunol 2011, 128:892-896.
145. Fahy J.V., Fleming H.E., Wong H.H., Liu J.T., Su J.Q., Reimann J., et al. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997, 155:1828-1834.
146. Berger P., Scotto-Gomez E., Molimard M., Marthan R., Le Gros V., Tunon-de-Lara J.M. Omalizumab decreases nonspecific airway hyperresponsiveness in vitro. Allergy 2007, 62:154-161.
147. Djukanovic R., Wilson S.J., Kraft M., Jarjour N.N., Steel M., Chung K.F., et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 2004, 170:583-593.
148. Kang J.Y., Kim J.W., Kim J.S., Kim S.J., Lee S.H., Kwon S.S., et al. Inhibitory effects of anti-immunoglobulin E antibodies on airway remodeling in a murine model of chronic asthma. J Asthma 2010, 47:374-380.
149. Mitzner W. Airway smooth muscle: the appendix of the lung. Am J Respir Crit Care Med 2004, 169:787-790.
150. Dyrda P., Tazzeo T., DoHarris L., Nilius B., Roman H.N., Lauzon A.M., et al. Acute response of airway muscle to extreme temperature includes disruption of actin-myosin interaction. Am J Respir Cell Mol Biol 2011, 44:213-221.
151. Danek C.J., Lombard C.M., Dungworth D.L., Cox P.G., Miller J.D., Biggs M.J., et al. Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs. J Appl Physiol 2004, 97:1946-1953.
152. Cox G., Miller J.D., McWilliams A., Fitzgerald J.M., Lam S. Bronchial thermoplasty for asthma. Am J Respir Crit Care Med 2006, 173:965-969.
153. Cox G., Thomson N.C., Rubin A.S., Niven R.M., Corris P.A., Siersted H.C., et al. Asthma control during the year after bronchial thermoplasty. N Engl J Med 2007, 356:1327-1337.
154. Pavord I.D., Cox G., Thomson N.C., Rubin A.S., Corris P.A., Niven R.M., et al. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med 2007, 176:1185-1191.
155. Duan W., Kuo I.C., Selvarajan S., Chua K.Y., Bay B.H., Wong W.S. Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am J Respir Crit Care Med 2003, 167:185-192.
156. Chopra L.C., Hucks D., Twort C.H., Ward J.P. Effects of protein tyrosine kinase inhibitors on contractility of isolated bronchioles of the rat. Am J Respir Cell Mol Biol 1997, 16:372-378.
157. Tsang F., Choo H.H., Dawe G.S., Wong W.S. Inhibitors of the tyrosine kinase signaling cascade attenuated thrombin-induced guinea pig airway smooth muscle cell proliferation. Biochem Biophys Res Commun 2002, 293:72-78.
158. Puddicombe S.M., Polosa R., Richter A., Krishna M.T., Howarth P.H., Holgate S.T., et al. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J 2000, 14:1362-1374.
159. Krymskaya V.P., Orsini M.J., Eszterhas A.J., Brodbeck K.C., Benovic J.L., Panettieri R.A., et al. Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. Am J Respir Cell Mol Biol 2000, 23:546-554.
160. Booth B.W., Adler K.B., Bonner J.C., Tournier F., Martin L.D. Interleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-alpha. Am J Respir Cell Mol Biol 2001, 25:739-743.
161. Vargaftig B.B., Singer M. Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR. Am J Physiol Lung Cell Mol Physiol 2003, 285:L808-L818.
162. Li X.H., Luan B. Effect of epidermal growth factor receptor on airway remodeling in asthmatic mice and its mechanism. Zhongguo Dang Dai Er Ke Za Zhi 2010, 12:137-140.
163. Tamaoka M., Hassan M., McGovern T., Ramos-Barbón D., Jo T., Yoshizawa Y., et al. The epidermal growth factor receptor mediates allergic airway remodelling in the rat. Eur Respir J 2008, 32:1213-1223.
164. Le Cras T.D., Acciani T.H., Mushaben E.M., Kramer E.L., Pastura P.A., Hardie W.D., et al. Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma. Am J Physiol Lung Cell Mol Physiol 2011, 300:L414-L421.
165. Hur G.Y., Lee S.Y., Lee S.H., Kim S.J., Lee K.J., Jung J.Y., et al. Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation. Exp Mol Med 2007, 39:367-375.
166. Berlin A.A., Lukacs N.W. Treatment of cockroach allergen asthma model with imatinib attenuates airway responses. Am J Respir Crit Care Med 2005, 171:35-39.
167. Rhee C.K., Kim J.W., Park C.K., Kim J.S., Kang J.Y., Kim S.J., et al. Effect of imatinib on airway smooth muscle thickening in a murine model of chronic asthma. Int Arch Allergy Immunol 2011, 155:243-251.
168. Huang M., Liu X., DU Q., Yao X., Yin K.S. Inhibitory effects of sunitinib on ovalbumin-induced chronic experimental asthma in mice. Chin Med J (Engl ) 2009, 122:1061-1066.
169. Bosse Y., Thompson C., Stankova J., Rola-Pleszczynski M. Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation. Am J Respir Cell Mol Biol 2006, 34:746-753.
170. Seow C.J., Chue S.C., Wong W.S. Piceatannol, a Syk-selective tyrosine kinase inhibitor, attenuated antigen challenge of guinea pig airways in vitro. Eur J Pharmacol 2002, 443:189-196.
171. Sakai H., Nishimura A., Watanabe Y., Nishizawa Y., Hashimoto Y., Chiba Y., et al. Involvement of Src family kinase activation in angiotensin II-induced hyperresponsiveness of rat bronchial smooth muscle. Peptides 2010, 31:2216-2221.
172. Matsunaga Y., Inoue H., Fukuyama S., Yoshida H., Moriwaki A., Matsumoto T., et al. Effects of a janus kinase inhibitor, pyridone 6, on airway responses in a murine model of asthma. Biochem Biophys Res Commun 2011, 404:261-267.
173. Kudlacz E., Conklyn M., Andresen C., Whitney-Pickett C., Changelian P. The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia. Eur J Pharmacol 2008, 582:154-161.